DrugPatentWatch Database Preview
Vertex Pharms Inc Company Profile
What is the competitive landscape for VERTEX PHARMS INC, and what generic alternatives to VERTEX PHARMS INC drugs are available?
VERTEX PHARMS INC has three approved drugs.
There are twenty-seven US patents protecting VERTEX PHARMS INC drugs.
There are two hundred and fifty-nine patent family members on VERTEX PHARMS INC drugs in thirty-three countries and twenty-four supplementary protection certificates in eleven countries.
Summary for Vertex Pharms Inc
| International Patents: | 259 |
| US Patents: | 27 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Vertex Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharms Inc | ORKAMBI | ivacaftor; lumacaftor | TABLET;ORAL | 206038-002 | Sep 28, 2016 | RX | Yes | No | 8,410,274 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor | TABLET, TABLET;ORAL | 210491-001 | Feb 12, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-002 | Mar 17, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-001 | Mar 17, 2015 | RX | Yes | No | 8,410,274 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Vertex Pharms Inc | ORKAMBI | ivacaftor; lumacaftor | TABLET;ORAL | 206038-001 | Jul 2, 2015 | RX | Yes | Yes | 9,670,163 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Vertex Pharms Inc | KALYDECO | ivacaftor | GRANULE;ORAL | 207925-002 | Mar 17, 2015 | RX | Yes | Yes | 9,670,163 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Vertex Pharms Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,956,052 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| 8,829,204 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| 8,614,327 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| 8,741,925 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| 7,659,268 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| 8,575,209 | Modulators of ATP-binding cassette transporters | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Vertex Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2009522278 | ➤ Sign Up |
| European Patent Office | 2502911 | ➤ Sign Up |
| European Patent Office | 2509954 | ➤ Sign Up |
| Eurasian Patent Organization | 201070698 | ➤ Sign Up |
| Canada | 2986286 | ➤ Sign Up |
| Japan | 2015511583 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Vertex Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2016 00019 | Denmark | ➤ Sign Up | PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPANCATBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOSYRE, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ELLER ET ESTERPRODRUG DERAF; REG. NO/DATE: EU/1/15/1059 20151124 |
| 2015000050 | Germany | ➤ Sign Up | PRODUCT NAME: N-(5-HYDROXY-2,4-DI-TERT-BUTYL-PHENYL)-4-OXO-1H-CHINOLIN-3-CARBONSAEUREAMID ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/12/782/001-002 20120723 |
| 0812 | Netherlands | ➤ Sign Up | PRODUCT NAME: 3-(6-((1-(2,2-DIFLUOR-1,3-BENZODIOXOL-5-YL)CYCLOPROPAANCARBONYL)AMINO)-3-METHYLPYRIDIN-2-YL)BENZOEZUUR, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/15/1059 20151124 |
| 2016015 | Lithuania | ➤ Sign Up | PRODUCT NAME: LUMAKAFTORAS/IVAKAFTORAS; REGISTRATION NO/DATE: EU/1/15/1059 20151119 |
| 0748 | Netherlands | ➤ Sign Up | PRODUCT NAME: N-(5-HYDROXY-2,4-DI-TERT-BUTYL-FENYL)-4-OXO-1H-CHINOLINE-3-CARBOXAMIDE (INN: IVACAFTOR) OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/12/782/001-002 20120725 |
| 0160015 00195 | Estonia | ➤ Sign Up | PRODUCT NAME: LUMAKAFTOOR / IVAKAFTOOR;REG NO/DATE: EU/1/15/1059 24.11.2015 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
